Mainstream

M&A Snapshot: Novartis to buy Tourmaline Bio for $1.4B, citing promise of heart drug pacibekitug

M&A Snapshot: Novartis to buy Tourmaline Bio for $1.4B, citing promise of heart drug pacibekitug

Post Contentnvs, trmlRead More

You might also be interested in reading Data Protection Bodies Call For ‘Privacy Threshold’ in Digital Euro Transactions.

September 9, 2025
In Mainstream